Mokhichekhra Boltaeva

Mokhichekhra Boltaeva

Auto-generated profile, based on publicly available information

Mokhichekhra Boltaeva


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2026 in International Academic Journal of Innovative Research
Verified
Journal Article
Open access
PDF file
LOLaziz Olimov
Laziz Olimov
MSMalakhat Saipova
Malakhat Saipova
AMAbdilmajid Mamatkabilov
Abdilmajid Mamatkabilov
UEUlugbek Esonturdiyev
Ulugbek Esonturdiyev
MBMokhichekhra Boltaeva
Mokhichekhra Boltaeva
ONOtabek Nazarov
Otabek Nazarov
The development of new drugs and the improvement of drug efficacy and safety through pharmacological innovation have been instrumental in managing many diseases. Even so, many people (~30–40%) do not respond to conventional drugs with poor therapeutic outcomes because of adverse drug reactions, low bioavailability, development of drug resistance, and lack of treatment specificity. This research review analyses some of the most recent pharmacological innovations aimed at improving therapeutic efficiency while minimizing the safety risks associated with treatment for diseases such as cancer, infections, cardiovascular conditions, and diabetes. Descriptive-analytical, review-based research was carried out by collating and assessing research papers, clinical trial reports, and documents accessible on the PubMed, Scopus, Google Scholar, and WHO databases, published between 2015 -2025. Of the over 120 relevant studies screened, 75 selected articles met the criteria for detailed review. They were systematically appraised in relation to innovative drug-delivery targeting systems, pharmacovigilance protocols, personalized treatment, and emerging drug-design principles. Results indicated that most innovative pharmacological approaches improved efficiency by 25–45% and reduced adverse drug reactions by 30% when used to treat chronic diseases. Innovative targeting drug delivery systems enhanced bioavailability by >50% compared to classical formulations used in the treatment of chronic diseases. In comparison, personalized approaches in oncology increased treatment response by 35% in patient care, and AI-aided drug discovery time was reduced by almost 60%. The article also concluded that innovative pharmacological interventions were effective in improving treatment and reducing the potential risks associated with therapy. It also concluded that continued implementation of a personalized approach to drug development, nanoformulations, and enhanced drug design techniques will be crucial for improving overall healthcare outcomes and future global disease management.

29 May 2026 in Journal of Internet Services and Information Security
Verified
Journal Article
Closed access
DRDelecta Jenifer Rajendren
Delecta Jenifer Rajendren
TTThiruvenkadam Thiagarajan
Thiruvenkadam Thiagarajan
.M.M.A.P. Manimekalai
.M.A.P. Manimekalai
.S.C.K. Sripavithra
.C.K. Sripavithra
MBMokhichekhra Boltaeva
Mokhichekhra Boltaeva
RKRavindra A. Kayande
Ravindra A. Kayande
Social media networks have emerged as important platforms for customer communication in brand communication. Nevertheless, enhancing the communication in a real-time environment and handling large and changing volumes of data is an important matter that brands have to consider. The main issue that the paper will respond to is how one can utilize real-time models to increase the effectiveness of brand communication on social media. The conventional approach does not work because of the necessity to adapt quickly to the ever-changing user behavior and preferences. The research paper suggests a real-time optimization framework using machine learning (ML) models and analyzing the pattern of social media engagement. Using a mixture of Natural Language Processing (NLP) and deep learning-powered algorithms, the model digests the data provided by users (user-generated content and engagement data, likes, shares, comments) in real-time. The methodology involves sentiment analysis, engagement prediction, and content recommendation systems, which create brand messages based on the existing emotional mood and interests of the audience. Some of the essential findings include that there were major increases in efficiency of communications, and the user engagement went up by 25 %, and sentiment alignment with targeted content increased by 15 % compared to traditional approaches. The indicators of performance are the rate of engagement, the accuracy of sentiment, and the processing speed of the model in real-time. The implications of this study are enormous for social media marketing tools. This is because brands are now able to provide more personalized and timely content, which has improved customer satisfaction and brand loyalty. In real-time, companies can improve their marketing ROI, proactively react to new trends, and build more emotional bonds with consumers by maximizing their communication strategies. The results of this paper allow pursuing research in the field of real-time analytics and AI-based strategies in digital marketing, with new process innovations to be more responsive and successful when communicating with the audience on social media platforms.